MATERIALS AND METHODS
C57BL/6 (H-2b) female mice, [6] [7] [8] [9] [10] weeks old, were obtained from Charles River Laboratories (Wilmington, MA). Mice treated with BCG (Tice strain, University of Illinois) were given 2 X 107 viable units intravenously. Bone marrow cells (from the femur and tibia) and spleen cells were obtained and suspended under sterile conditions as previously described (10) . Immunization in vitro was carried out according to a modification of the procedure of Mishell and Dutton (11) . Samples containing 2 X 107 viable spleen cells (H-2b) were cultured with 2 X 105 irradiated (4000 rads, 40 J/kg) P815-Y mastocytoma cells (H-2d) in 35 X 10 mm plastic dishes in a total volume of 1 ml. The medium was RPMI 1640 supplemented with heat-inactivated dialyzed fetal calf serum (5%), glutamine (2 mM), sodium pyruvate (1 mM), 10OX nonessential amino acids (1%), penicillin (100 units/ml), streptomycin (100 ,gg/ml), and 2-mercaptoethanol (50 ,gM). Cultures were incubated for 4 days at 370C in an atmosphere of 10% CO2 in air and were fed daily with 0.1 ml of RPMI 1640 medium supplemented with penicillin, streptomycin, fetal calf serum (33%), 5OX essential amino acids (6%), 10OX nonessential amino acids (3%), glutamine (6 mM), sodium bicarbonate (200 AM), and glucose (100 mM). At the end of culture, cells were agitated with a rubber policeman, collected, washed, and counted. After viability was assessed by trypan blue dye exclusion, cells were adjusted to appropriate concentrations in RPMI 1640 medium with 5% fetal calf serum. Cell-mediated immunity against P815-Y target cells was measured using both the 4-hr 5lCr release assay (12) and the 48-hr growth inhibition assay (13) . The percent 51Cr released and the percent growth inhibition were calculated in the following way: [2] in which T is the number of target cells remaining in the presence of test lymphocytes and N is the number of target cells remaining in the presence of normal lymphocytes. Cells were fractionated on a nylon wool column as previously described (14) . To prepare T cell-deprived ("B") mice, normal mice were thymectomized, lethally irradiated (750 rads, 7.5 J/kg) 14 days after thymectomy, then reconstituted intravenously with 2 X 107 syngeneic bone marrow cells 24 hr after irradiation.
RESULTS
As shown in Table 1 BCG. None of these populations was inhibitory when added to already sensitized effector cells (data not shown).
BCG also had a marked influence on the number of cells in both the bone marrow and spleen (Fig. 1) . Within 2 days after the administration of BCG, there was a 40% decrease in the number of cells found in the bone marrow, and this decrease was still apparent 16 days after BCG. On the other hand, the number of spleen cells began to increase 7 days after BCG and continued to increase sharply for another 9 days.
In our previous work (9) and that of others (6) the spleen cell population from BCG-treated mice that suppressed in vitro immunization was localized to a nylon wool adherent fraction. The suppressive activity of nylon wool-adherent spleen cells from B mice and from B mice treated with BCG is shown in Table 2 . Addition of 107 adherent cells from B mice caused a significant reduction in the immunization of normal spleen cells. Addition of a similar number of adherent cells from normal spleen had no effect. BCG treatment of B mice further enhanced the suppressive activity within their spleens such that 107 adherent cells almost completely prevented the in vitro immunization of normal spleen cells. In summary, suppressor cells that inhibit in vitro immunization are present in normal bone marrow. BCG increases the activity of the natural suppressor cells and elicits similar cells in the spleen, perhaps through migration of bone marrow elements. While the overall effect of BCG in vivo is usually one of adjuvancy, these results underscore BCG's ability to stimulate intrinsic suppressor elements of immunity as well. It is conceivable that adjuvancy itself may always be the resultant of concomitant stimulation of both helper and suppressor forces.
